| RS2531335997 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2531337541 |
COL7A1
|
Health Risk |
Likely pathogenic |
COL7A1-related disorder, COL7A1-related disorder |
| RS2531338234 |
RASA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation 1 |
| RS2531338258 |
RASA1
|
Health Risk |
Likely pathogenic |
RASA1-related disorder, RASA1-related disorder |
| RS2531339000 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Vascular malformation |
| RS2531339089 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2531341953 |
RASA1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2531342060 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2531342144 |
RASA1
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Capillary malformation-arteriovenous malformation syndrome |
| RS2531344354 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2531344417 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2531345873 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2531347318 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2531347369 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2531347823 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2531348163 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2531350017 |
RASA1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2531350156 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2531351123 |
COL7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
7 conditions, Epidermolysis bullosa dystrophica |
| RS2531355164 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2531355519 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation 1, Capillary malformation-arteriovenous malformation 1 |
| RS2531359738 |
RASA1
|
Health Risk |
Likely pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2531359826 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2531360007 |
RASA1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2531362827 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2531362861 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2531363692 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2531364797 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531365245 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2531365389 |
ADGRV1
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2C, Usher syndrome type 2C |
| RS2531366088 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2531366212 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531366507 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2531367728 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531369305 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531373838 |
RASA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation 1 |
| RS2531373996 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2531375175 |
IFT122
|
Health Risk |
Pathogenic |
Cranioectodermal dysplasia 1, Cranioectodermal dysplasia 1 |
| RS2531378919 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2531378940 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2531380191 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2531381385 |
ADGRV1
|
Health Risk |
Likely pathogenic |
— |
| RS2531393831 |
KIF2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2531395817 |
RASA1
|
Health Risk |
Likely pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2531395894 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2531396047 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2531396312 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2531404825 |
RASA1
|
Health Risk |
Likely pathogenic |
RASA1-related disorder, RASA1-related disorder |
| RS2531404919 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2531429983 |
IFT122
|
Health Risk |
Pathogenic |
Cranioectodermal dysplasia 1, Cranioectodermal dysplasia 1 |
| RS2531442889 |
UQCRC1
|
Health Risk |
Likely pathogenic |
Parkinsonism with polyneuropathy, Parkinsonism with polyneuropathy |
| RS2531458645 |
IFT122
|
Health Risk |
Pathogenic |
Cranioectodermal dysplasia 1, Cranioectodermal dysplasia 1 |
| RS2531459837 |
PCSK1
|
Health Risk |
Pathogenic |
Obesity due to prohormone convertase I deficiency, Obesity due to prohormone convertase I deficiency |
| RS2531471911 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS2531471980 |
HSD17B4
|
Health Risk |
Pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS2531472105 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS2531482062 |
MRE11
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia-like disorder, Ataxia-telangiectasia-like disorder |
| RS2531485722 |
SMARCA5
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS2531495848 |
OBSCN
|
Health Risk |
Likely pathogenic |
Rhabdomyolysis, susceptibility to |
| RS2531495892 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome |
| RS2531496314 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS2531497410 |
SMARCA5
|
Health Risk |
Pathogenic |
Short stature, Failure to thrive |
| RS2531503998 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531504282 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531504436 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531505680 |
PCSK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Obesity due to prohormone convertase I deficiency, Body mass index quantitative trait locus 12 |
| RS2531511686 |
SMARCA5
|
Health Risk |
Pathogenic |
Pes planus, Delayed CNS myelination |
| RS2531513538 |
PCSK1
|
Health Risk |
Likely pathogenic |
Obesity due to prohormone convertase I deficiency, Obesity due to prohormone convertase I deficiency |
| RS2531516441 |
OBSCN
|
Health Risk |
Pathogenic |
— |
| RS2531530527 |
CWC27
|
Health Risk |
Likely pathogenic |
— |
| RS2531537816 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531538042 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531540473 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531540640 |
IL7R
|
Health Risk |
Pathogenic |
Immunodeficiency 104, Immunodeficiency 104 |
| RS2531540786 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531541261 |
ATP2C1
|
Health Risk |
Likely pathogenic |
Familial benign pemphigus, Familial benign pemphigus |
| RS2531541423 |
ATP2C1
|
Health Risk |
Likely pathogenic |
Familial benign pemphigus, Familial benign pemphigus |
| RS2531546547 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531547578 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531547862 |
IL7R
|
Health Risk |
Pathogenic |
Immunodeficiency 104, Immunodeficiency 104 |
| RS2531547976 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531570514 |
IL7R
|
Health Risk |
Pathogenic |
Immunodeficiency 104, Immunodeficiency 104 |
| RS2531574631 |
CELSR3
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2531575367 |
IL7R
|
Health Risk |
Pathogenic |
Immunodeficiency 104, Immunodeficiency 104 |
| RS2531575374 |
IL7R
|
Health Risk |
Pathogenic |
Immunodeficiency 104, Immunodeficiency 104 |
| RS2531580019 |
OBSCN
|
Health Risk |
risk factor |
Rhabdomyolysis, susceptibility to |
| RS2531580325 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2531580353 |
IL7R
|
Health Risk |
Pathogenic |
Immunodeficiency 104, Immunodeficiency 104 |
| RS2531583251 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2531583528 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2531584092 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2531588221 |
PROM1
|
Health Risk |
Pathogenic |
— |
| RS2531598967 |
HSD17B4
|
Health Risk |
Pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS2531599204 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome 1 |
| RS2531599262 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS2531599299 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome 1 |
| RS2531599625 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS2531609463 |
HSD17B4
|
Health Risk |
Pathogenic |
Perrault syndrome, Bifunctional peroxisomal enzyme deficiency |
| RS2531609485 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome 1 |
| RS2531609558 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |